Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021

  • ID: 4403354
  • Report
  • Region: Global
  • 74 pages
  • TechNavio
OFF
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

1 of 5

FEATURED COMPANIES

  • Advanced Cell Diagnostics
  • BioCep
  • BioFluidica
  • Clearbridge Biomedics
  • Cynvenio
  • Fluxion Biosciences
  • MORE
About Circulating Tumor Cell (CTC) Diagnostics

Cancer is diagnosed by blood count, bone marrow biopsy, and molecular identification of mutated cells. CTC diagnostics helps in the identification of deoxyribonucleic acid (DNA) shed by tumor cells. CTCs are cancerous cells which detach from primary tumor and migrate in the bloodstream or lymphatic system of the patient. CTCs in the blood or lymphatic system helps in providing important information regarding prognosis and treatment effectiveness for cancer patients.

The analysts forecast the global circulating tumor cell (CTC) diagnostics market to grow at a CAGR of 9.39% during the period 2017-2021.

Covered in this report
The report covers the present scenario and the growth prospects of the global circulating tumor cell (CTC) diagnostics market for 2017-2021. To calculate the market size, the report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography:
  • Americas
  • APAC
  • EMEA
The report, Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors
  • ApoCell
  • Qiagen
  • Menarini Silicon Biosystems
Other prominent vendors
  • Advanced Cell Diagnostics
  • BioCep
  • BIOCEPT
  • BioFluidica
  • Celltraffix
  • Clearbridge Biomedics
  • Creatv MicroTech
  • Cynvenio
  • Epic Sciences
  • Fluxion Biosciences
  • Gilupi
  • Ikonisys
  • IVDiagnostics
  • ScreenCell
Market drivers
  • Increasing incidences of cancer
  • For a full, detailed list, view the full report
Market challenges
  • High cost of diagnostics
  • For a full, detailed list, view the full report
Market trends
  • Introduction of advanced detection technologies
  • For a full, detailed list, view the full report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
You can request one free hour of the analyst’s time when you purchase this market report. Details are provided within the report.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Advanced Cell Diagnostics
  • BioCep
  • BioFluidica
  • Clearbridge Biomedics
  • Cynvenio
  • Fluxion Biosciences
  • MORE
PART 01: Executive summary

PART 02: Scope of the report

PART 03: Research Methodology

PART 04: Introduction
  • Market outline
PART 05: Market landscape
  • Market overview
  • Market size and forecast
  • Five forces analysis
PART 06: Market segmentation by end-user
  • Market overview
PART 07: Geographical segmentation
  • Overview
  • Americas
  • EMEA
  • APAC
PART 08: Decision framework

PART 09: Drivers and challenges
  • Market drivers
  • Market challenges
PART 10: Market trends
  • Introduction of advanced detection technologies
  • Application of CTC as biomarkers for drug discovery
PART 11: Vendor landscape
  • Competitive scenario
PART 12: Key vendor analysis
  • ApoCell
  • Menarini Silicon Biosystems
  • Qiagen
  • Other prominent vendors
PART 13: Appendix
  • List of abbreviations
List of Exhibits
Exhibit 01: Global CTC diagnostics market 2016-2021: Overview
Exhibit 02: Global CTC diagnostics market 2016-2021 ($ billions)
Exhibit 03: Five forces analysis
Exhibit 04: Global CTC diagnostics market by end-user 2016-2021: Overview
Exhibit 05: Global CTC diagnostics market segmentation by end-user 2016
Exhibit 06: Impact assessment of global CTC diagnostics market 2016-2021
Exhibit 07: Buying criteria for end-users in global CTC diagnostics market 2016
Exhibit 08: Global CTC diagnostics market by geography 2016-2021: Overview
Exhibit 09: CTC diagnostics market in Americas 2016-2021: Overview
Exhibit 10: CTC diagnostics market in Americas 2016-2021 ($ billions)
Exhibit 11: Americas: Market metrics in various countries
Exhibit 12: CTC diagnostics market in Americas: Future outlook
Exhibit 13: CTC diagnostics market in EMEA 2016-2021: Overview
Exhibit 14: CTC diagnostics market in EMEA 2016-2021 ($ billions)
Exhibit 15: EMEA: Market metrics in various countries
Exhibit 16: CTC diagnostics market in EMEA: Future outlook
Exhibit 17: CTC diagnostics market in APAC 2016-2021: Overview
Exhibit 18: CTC diagnostics market in APAC 2016-2021 ($ billions)
Exhibit 19: APAC: Market metrics in various countries
Exhibit 20: CTC diagnostics market in APAC: Future outlook
Exhibit 21: Breast cancer statistics in various countries
Exhibit 22: Competitive structure analysis of global CTC diagnostics market 2016
Exhibit 23: Competitive landscape analysis of global CTC diagnostics market 2016
Exhibit 24: Strategic success factors of companies in global CTC diagnostics market 2016
Exhibit 25: ApoCell: Key highlight
Exhibit 26: ApoCell: Strength assessment
Exhibit 27: ApoCell: Strategy assessment
Exhibit 28: ApoCell: Opportunity assessment
Exhibit 29: Menarini Silicon Biosystems: Key highlights
Exhibit 30: Menarini Silicon Biosystems: Strength assessment
Exhibit 31: Menarini Silicon Biosystems: Strategy assessment
Exhibit 32: Menarini Silicon Biosystems: Opportunity assessment
Exhibit 33: Qiagen: Key highlights
Exhibit 34: Qiagen: Strength assessment
Exhibit 35: Qiagen: Strategy assessment
Exhibit 36: Qiagen: Opportunity assessment
Exhibit 37: Other prominent vendors
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Advanced Cell Diagnostics
  • BioCep
  • BioFluidica
  • Clearbridge Biomedics
  • Cynvenio
  • Fluxion Biosciences
  • MORE
New Report Released: – Global Circulating Tumor Cell (CTC) Diagnostics Market 2017-2021

The author of the report recognizes the following companies as the key players in the global circulating tumor cell (CTC) diagnostics market: ApoCell, Qiagen, and Menarini Silicon Biosystems.

Other Prominent Vendors in the market are: Advanced Cell Diagnostics, BioCep, BIOCEPT, BioFluidica, Celltraffix, Clearbridge Biomedics, Creatv MicroTech, Cynvenio, Epic Sciences, Fluxion Biosciences, Gilupi, Ikonisys, IVDiagnostics, and ScreenCell.

Commenting on the report, an analyst from the research team said: “One trend in the market is introduction of advanced detection technologies. Cancer is a lethal disease taking toll across the geographical regions. The use of advanced technologies has helped in early diagnosis of cancer and improved treatment in patients. Diagnostic imaging technology has introduced molecular imaging technique for the detection of cancerous cells.”

According to the report, one driver in the market is increasing incidences of cancer. Cancer is one of the lethal diseases, which has increased mortality rate worldwide. Various types of cancer occur due to genetic changes, high consumption of alcohol, smoking, and other lifestyle changes. The overall burden of cancer is increasing across the globe. Some of the most common type of cancers are breast cancer, colon cancer, prostate cancer, lung and bronchus cancer, kidney cancer, pancreatic cancer, leukemia, and melanoma of skin.

Further, the report states that one challenge in the market is high cost of diagnostics. Cancer treatment covers the majority of healthcare expenditure in most of the countries across the world. Cancer drug expenditure is also increasing in the countries. The treatment and diagnosis cost of cancer cases such as leukemia, multiple myeloma, and lymphoma is high compared to the treatment and prognosis of pancreatic, melanoma, and thyroid cancer. In developed countries such as the US, Medicare covers about 60%-80% of the treatment and diagnosis cost for cancer cases. With the availability of POC detection for cancer diagnosis, the overall cost of diagnosis increases.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Note: Product cover images may vary from those shown
5 of 5
  • ApoCell
  • Qiagen
  • Menarini Silicon Biosystems
  • Advanced Cell Diagnostics
  • BioCep
  • BIOCEPT
  • BioFluidica
  • Celltraffix
  • Clearbridge Biomedics
  • Creatv MicroTech
  • Cynvenio
  • Epic Sciences
  • Fluxion Biosciences
  • Gilupi
  • Ikonisys
  • IVDiagnostics
  • ScreenCell
Note: Product cover images may vary from those shown
6 of 5
Note: Product cover images may vary from those shown
Adroll
adroll